8:32
Candel Therapeutics (NASDAQ: $CADL): Revolutionizing Glioma Treatment and Redefining Hope
Benzinga Partner Studio
11:06
Candel Therapeutics (NASDAQ: $CADL) Reports Positive Data From Phase 2 Trial Of CAN-2409
11:08
$CADL enLIGHTEN Discovery Platform Aims To Tackle Complexities Of Tumor Microenvironments
